ZEB2 and liver cancer: Japanese scholar Yamada found that EMT‐induced transcription factors and mesenchymal markers Twist 1 and ZEB‐2 were significantly overexpressed in liver cancer, and patients with mesenchymal tumors were more likely to have early recurrence than those with epithelial tumors.42